Paul Armentano has over two decades experience working professionally in cannabis policy. He is the Deputy Director of NORML. He also serves on the faculty of Oaksterdam University in Oakland, where he is the Chair of Science. His writing on cannabis and cannabis policy has appeared in over 1,000 publications, scholarly and/or peer-reviewed journals, as well as in more than two dozen textbooks and anthologies. He is a regular contributor to TheHill.com as well as to numerous other print and online publications. Mr. Armentano is the co-author of the book Marijuana is Safer: So Why Are We Driving People to Drink? (2009, Chelsea Green), which has been licensed and translated internationally. He is also the author of the book The Citizen’s Guide to State-By-State Marijuana Laws (2015), available from Whitman Publishing. He is the author and editor of the NORML-produced publication Emerging Clinical Applications for Cannabis and Cannabinoids, which summarizes over 400 peer-reviewed studies specific to the safety and efficacy of cannabis among different patient populations. Mr. Armentano was the principal investigator for defense counsel in the federal case US v Schweder et al., one of the first legal cases in decades to challenge the constitutionality of cannabis as a schedule I controlled substance. He was also an expert in the successful Canadian constitutional challenge, Allard v Canada, which preserved qualified patients right to grow cannabis at home. He is the 2013 Freedom Law School Health Freedom Champion of the Year and the 2013 Alfred R. Lindesmith award recipient in the achievement in the field of scholarship. He is the 2019 Al Horn Memorial Award recipient in appreciation of advancing the cause of justice. Mr. Armentano works closely with numerous state and federal politicians with regard to drafting and enacting marijuana policy reforms, and he is a frequently sought speaker on the topic at legal and academic seminars.

photo of phone with two people taking selfie

Leveraging User-Generated Content for Community Engagement: Strategies and Benefits

As cannabis brands and retailers look to expand their reach and connect with canna-curious and canna-averse audiences, traditional marketing strategies must evolve to better connect with folks who lack knowledge about or have negative perceptions of cannabis. One of the most powerful tools at cannabis marketers’ disposal is also frequently overlooked: user-generated content, or UGC…

cannabis and edibles in glass jar

Cannabis Consumption Methods: A Guide to Promoting Benefits and Addressing Concerns

We’ve come a long way from the era of simply rolling up and sparking a joint. Cannabis’s boom in popularity has spawned new products for those less sure about smoking, such as edibles, tinctures, vaporizers or topical applications. While there are now a myriad of alternative consumption methods, new users can feel overwhelmed with what’s available on dispensary shelves…

Does Increased Potency Mean Modern Cannabis is More Dangerous?

For decades, opponents of cannabis legalization have alleged that today’s cannabis is more potent, and therefore more potentially dangerous to health, than that enjoyed by previous generations. But despite this opinion’s popularity, there exists little real-world support for it. Regulation Works, Prohibition Doesn’t Frustrated by the rapid spread of cannabis legalization, opponents across the country…

Combatting the Claim that Medical Cannabis is a Charade

Colorado residents voted to legalize the use of cannabis to treat debilitating medical conditions some two decades ago. Nonetheless, prohibitionists still argue that “marijuana is not medicine.” However, the majority of the public and the medical establishment disagree.  Specifically:  More than nine out of 10 Americans believe that cannabis should be legal for medical or…